The Cooper Companies, Inc. (NYSE:COO) will present at the William Blair 34th Annual Growth Stock Conference in Chicago, Illinois, on June 12, 2014. Greg W. Matz, Vice President, Chief Financial Officer & Chief Risk Officer, will represent the Company in a presentation scheduled to begin at 10:20AM ET. The Cooper Companies, Inc. (NYSE:COO) net profit margin is 22.80% and weekly performance is -2.30%. On last trading day company shares ended up $130.15. Analysts mean target price for the company is $141.11. The Cooper Companies, Inc. (NYSE:COO) distance from 50-day simple moving average (SMA50) is -1.65%.
Atrion Corporation (NASDAQ:ATRI) announced a quarterly dividend on Thursday, May 22nd, American Banking News reports. Stockholders of record on Monday, June 16th will be paid a dividend of 0.64 per share on Monday, June 30th. This represents a $2.56 annualized dividend and a dividend yield of 0.81%. Atrion Corporation (NASDAQ:ATRI) shares advanced 0.56% in last trading session and ended the day on $316.99. ATRI Gross Margin is 47.80% and its return on assets is 15.80%. Atrion Corporation (NASDAQ:ATRI) quarterly performance is 11.97%.
TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”) announced on 21 May 2014 that its Chief Executive Officer, Elias Vamvakas, will participate in the 11th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May 28, 2014. The conference will be held at the Minneapolis Marriott City Center Hotel. TearLab Corp (NASDAQ:TEAR) shares moved down -0.66% in last trading session and was closed at $4.54, while trading in range of $4.51 – $4.62. TearLab Corp (NASDAQ:TEAR) year to date (YTD) performance is -51.39%.
Utah Medical Products, Inc (NASDAQ:UTMD) declared a quarterly dividend on Wednesday, May 7th, AnalystRatingsNetwork reports. Stockholders of record on Wednesday, June 18th will be given a dividend of 0.25 per share on Thursday, July 3rd. This represents a $1.00 dividend on an annualized basis and a yield of 1.99%. The ex-dividend date of this dividend is Monday, June 16th. Utah Medical Products, Inc. (NASDAQ:UTMD) ended the last trading day at $47.37. Company weekly volatility is calculated as 3.00% and price to cash ratio as 11.80. Utah Medical Products, Inc. (NASDAQ:UTMD) showed a negative weekly performance of -0.38%.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) reported revenue of $1.9 billion in the first quarter of 2014, an increase of 77% compared with last year’s earnings, according to a press release. The company also reported an increase in its developed market revenue of $1.4 billion, up 82% from the first quarter of 2013 as a result of promoted dermatology brands, consumer, neurology and other, and oral health businesses, as well as a 9% organic growth in Bausch + Lomb businesses, the release said. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) net profit margin is -13.10% and weekly performance is 5.29%. On last trading day company shares ended up $133.46. Analysts mean target price for the company is $52.38. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) distance from 50-day simple moving average (SMA50) is 2.13%.
Leave a Reply